Opaleye Management Inc. - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 148 filers reported holding VIKING THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opaleye Management Inc. ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$3,320,000
-31.1%
400,000
-17.5%
1.01%
-24.2%
Q1 2019$4,821,000
-23.6%
485,000
-41.2%
1.34%
-43.3%
Q4 2018$6,311,000
-56.1%
825,0000.0%2.36%
-35.6%
Q3 2018$14,371,000
+26.2%
825,000
-31.2%
3.66%
+24.0%
Q2 2018$11,388,000
+136.8%
1,200,000
+9.0%
2.95%
+114.4%
Q1 2018$4,810,000
+146.5%
1,100,800
+129.1%
1.38%
+120.0%
Q4 2017$1,951,000480,5580.62%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders